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ABSTRACT
When assessing the properties of chemicals, the easiest and most consistent way of applying 
(Quantitative) Structure-Activity Relationship ([Q]SAR) models is to use ready-made 
software that implements the models via a user-friendly interface. A wide range of software 
tools are available for predicting physicochemical properties, toxicological endpoints and 
other biological effects, as well as fate in the environment and biological organisms. 
Typically, a given software package predicts multiple properties and endpoints, and some are 
extensible, allowing the user to develop new models or include new knowledge. In addition to 
(Q)SAR models and rulebases that are incorporated in software tools, there is a growing 
scientific literature which reports thousands of (Q)SARs.
In this report, we give an overview of the software packages that are commonly used in the 
assessment of chemical toxicity. These software packages are potentially useful in the hazard 
and risk assessment of chemicals, including for regulatory purposes. However, the 
applicability of any given software tool needs to be carefully evaluated and documented.
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11. Introduction
The following sections briefly describe software tools for toxicity prediction that are either in 
the public domain or commercially available. Some of the freely available software tools have 
been developed under the terms of open-source licenses, which means that other experts can 
further develop and disseminate the software (Jeliazkova et al, 2010). Websites for the 
various tools are given in Tables 1 and 2, and their ability to predict properties and endpoints 
relevant to toxicity assessment is highlighted in Table 3. Some of these tools were evaluated 
by an ECETOC Task Force (ECETOC, 2003).
This review focuses on software tools for toxicity prediction, and complements a recent 
review on software tools for predicting biokinetic (ADME) properties (Mostrag-Szlichtyng & 
Worth, 2010).
2. Freely available software 
A summary of freely available software is given in Table 1. The following paragraphs 
describe these tools in general terms.
2.1. Caesar models
A series of statistically-based models, developed within EU-funded CAESAR project 
(http://www.caesar-project.eu), have been implemented into open-source software and made 
available for online use via the web. Predictions are made for five endpoints: mutagenicity 
(Ames), carcinogenicity, developmental toxicity, skin sensitisation, and the bioconcentration 
factor.
2.2. EPI Suite
EPI (Estimation Programs Interface) Suite estimates a range of physicochemical properties, 
environmental fate parameters and ecotoxicity. It has been developed by the US EPA in 
collaboration with Syracuse Research Corporation (SRC), and is used widely by 
governmental and industry organisations to support the assessment of new and existing 
industrial chemicals. EPI Suite is freely downloadable from the US EPA website: 
http://www.epa.gov/oppt/exposure/pubs/episuite.htm
2.3. Lazar
Lazar is an open-source software programme that makes predictions of toxicological 
endpoints (currently, mutagenicity, human liver toxicity, rodent and hamster carcinogenicity, 
MRDD) by analysing structural fragments in a training set (Helma, 2006; Maunz & Helma, 
2008). It is based on the use of statistical algorithms for classification (k-nearest neighbours 
and kernel models) and regression (multi-linear regression and kernel models). In contrast to 
traditional k-NN techniques, Lazar treats chemical similarities not in absolute values, but as 
toxicity dependent values, thereby capturing only those fragments that are relevant for the 
toxic endpoint under investigation. Lazar performs automatic applicability domain estimation 
and provides a confidence index for each prediction, and is usable without expert knowledge. 
Lazar runs under Linux and a web-based prototype is also freely accessible: http://lazar.in-
silico.de/
22.4. OECD QSAR Application Toolbox
The OECD QSAR Application Toolbox is a standalone software application for gaps in 
(eco)toxicity data needed for assessing the hazards of chemicals. Data gaps are filled by 
following a flexible workflow in which chemical categories are built and missing data are 
estimated by read-across or by applying local QSARs (trends within the category). The 
Toolbox also includes a range of profilers to quickly evaluate chemicals for common 
mechanisms or modes of action. In order to support read-across and trend analysis, the 
Toolbox contains numerous databases with results from experimental studies. The first 
version of the Toolbox, released in March 2008, was a proof-of-concept version. The first 
update (version 1.1) was released in December 2008.  The second phase of the project to 
develop a more comprehensive Toolbox which fully implements the capabilities of the first 
version was launched in November 2008 with a four-year timeline. The OECD Toolbox is 
freely available from the OECD website: http://www.oecd.org/env/existingchemicals/qsar
2.5. OncoLogic
This is an expert system that assesses the potential of chemicals to cause cancer. OncoLogic® 
was developed by the US EPA in collaboration with LogiChem, Inc. It predicts the potential 
carcinogenicity of chemicals by applying the rules of SAR analysis and incorporating what is 
known about the mechanisms of action and human epidemiological studies. The software 
reveals its line of reasoning, like human experts, to support predictions made. It also includes 
a database of toxicological information relevant to carcinogenicity assessment. The Cancer 
Expert System is comprised of four subsystems that evaluate fibres, metals, polymers, and 
organic chemicals of diverse chemical structures. Chemicals are entered one-by-one and the 
user needs a limited knowledge of chemistry in order to select the appropriate subsystem.
OncoLogic is freely downloadable from the US EPA website: 
http://www.epa.gov/oppt/sf/pubs/oncologic.htm
2.6. Toxtree
Toxtree is a flexible and user-friendly open-source application that places chemicals into 
categories and predicts various kinds of toxic effect by applying decision tree approaches. It is 
freely available from the JRC website: http://ecb.jrc.ec.europa.eu/qsar/qsar-
tools/index.php?c=TOXTREE
Toxtree has been developed by the JRC in collaboration with various consultants, in particular 
Ideaconsult Ltd (Sofia, Bulgaria). A key feature of Toxtree is the transparent reporting of the 
reasoning underlying each prediction. Toxtree v 1.60 (July 2009) includes classification 
schemes for systemic toxicity (Cramer scheme and extended Cramer scheme), as well as 
mutagenicity and carcinogenicity (Benigni-Bossa rulebase and the ToxMic rulebase on the in 
vivo micronucleus assay). The Cramer scheme is probably the most widely used approach for 
structuring chemicals in order to make an estimation of the Threshold of Toxicological 
Concern (TTC). 
The current version of Toxtree (v2.1.0, June 2010) also applies the TTC scheme of Kroes et 
al. (2004), alerts for skin sensitisation alerts (Enoch et al, 2008), and SMARTCyp, a two-
dimensional method for the prediction of cytochrome P450-mediated metabolism (Rydberg 
et al, 2010). SMARTCyp predicts which sites in a molecule are labile for metabolism by 
Cytochromes P450.
32.7. PASS
This tool, developed by the Institute of Biomedical Chemistry of the Russian Academy of 
Medical Sciences, Moscow is a computerised system for the Prediction of Activity Spectra for 
Substances. It predicts several specific toxicities among them mutagenicity, carcinogenicity, 
teratogenicity and embryotoxicity, and also mechanisms of action and pharmacological 
effects. The system predicts the probability (Pa) of a biological activity for a new compound, 
by estimating the similarity/dissimilarity of the new substance to substances with well known 
biological activities present in the training set (70 000 compounds). The tool also gives a 
cross reference between biological activities on the basis of the knowledgebase of 
mechanism-effect relationships. An online version of PASS is available at: 
http://195.178.207.233/PASS/index.html
2.8. T.E.S.T.
The Toxicity Estimation Software Tool is an open-source application developed by the US 
EPA. It estimates the toxicity of a compound by applying several QSAR methodologies thus 
allowing the user to have greater confidence in predicted toxicities. Among other toxicities it 
predicts rat oral LD50, Ames mutagenicity, developmental toxicity, as well as acute toxicity 
to fish (fathead minnow), Daphnia magna and Tetrahymena pyriformis. The tool is freely 
downloadable from the EPA website
(http://www.epa.gov/nrmrl/std/cppb/qsar/index.html#TEST). The models are well 
documented and the training set is made available as structure files (SDF file).  
43. Commercially available software 
A summary of commercially available software is given in Table 2. The following paragraphs 
describe these tools in general terms.
3.1. ACD/Tox Suite
The ACD/Tox Suite (formerly called ToxBoxes), provided by ACD/Labs and Pharma 
Algorithms, provides predictions of various toxicity endpoints including hERG inhibition, 
genotoxicity, CYP3A4 inhibition, ER binding affinity, irritation, rodent LD50, aquatic 
toxicity, and organ-specific health effects (http://www.acdlabs.com/products/admet/tox/). The 
predictions are associated with confidence intervals and probabilities, thereby providing a 
numerical expression of prediction reliability.  The software incorporates the ability to 
identify and visualize specific structural toxicophores, giving insight as to which parts of the 
molecule are responsible for the toxic effect. It also identifies analogues from its training set, 
which can also increase confidence in the prediction. Predictions are based on data from over 
100,000 compounds. The algorithms and datasets not disclosed. A web version of the 
software is freely accessible at http://www.pharma-algorithms.com/webboxes/
3.2. ADMET Predictor
This is software developed by Simulations Plus (http://www.simulations-plus.com/) for the 
predictive modelling of ADMET (Absorption, Distribution, Metabolism, Elimination, and 
Toxicity) properties. It includes a number of in-built models for ADMET, and allows new 
predictive models to be built from the user's data.
3.3. BioEpisteme
This is primarily a research tool developed by the Prous Institute for Biomedical Research
(http://www.prousresearch.com/). It is organised into two main modules: a model building 
module and a data prediction module. The model building module provides a range of 2D and 
3D descriptors; the data prediction module predicts adverse effects. It appears to have been 
developed mainly for applications in the pharmaceutical industry.
3.4. Derek
Derek for Windows (DfW) is a SAR-based system is developed by Lhasa Ltd, a non-profit 
company and educational charity (https://www.lhasalimited.org/). DfW contains over 50 
alerts covering a wide range of toxicological endpoints in humans, other mammals and 
bacteria. An alert consists of a toxicophore (a substructure known or thought to be responsible 
for the toxicity) and is associated with literature references, comments and examples. A key 
feature of DfW is the transparent reporting of the reasoning underlying each prediction.
All the rules in DfW are based either on hypotheses relating to mechanisms of action of a 
chemical class or on observed empirical relationships. Information used in the development of 
rules includes published data and suggestions from toxicological experts in industry, 
regulatory bodies and academia. The toxicity predictions are the result of two processes. The 
program first checks whether any alerts in the knowledge base match toxicophores in the 
query structure. The reasoning engine then assesses the likelihood of a structure being toxic. 
There are nine levels of confidence: certain, probable, plausible, equivocal, doubted, 
improbably, impossible, open, contradicted. Derek can be integrated with Lhasa’s Meteor 
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parent compounds and their metabolites.
3.5. HazardExpert
This is a module of the Pallas software developed by CompuDrug (http://compudrug.com/). It 
predicts the toxicity of organic compounds based on toxic fragments, and it also calculates 
bioavailability parameters (from logP and pKa). It is a rule-based system with an open 
knowledge base, allowing the user to expand or modify the data on which the toxicity 
estimation relies. It covers the following endpoints relevant to dietary toxicity assessment: 
carcinogenicity, mutagenicity, teratogenicity, membrane irritation, immunotoxicity and 
neurotoxicity. A further application of the program is prediction the toxicity of the parent 
compound and its metabolites by linking with MetabolExpert, another module of the Pallas 
software.
3.6. MDL QSAR
This is primarily a research tool, originally developed and marketed by MDL, and now by 
Symyx (http://www.symyx.com/). It enables the user to build and apply new QSARs, 
supporting model development by providing over 400 built-in 2D and 3D molecular 
descriptor calculators. It includes a variety of predictive modules, including rodent 
carcinogenicity (FDA model).
3.7. Molcode Toolbox
This is a commercial tool developed and marketed by Molcode Ltd (http://molcode.com/). It 
has a range of modules for predicting toxicological endpoints and ADME properties. The 
models are well documented and the underlying experimental data is made available with 
references and structure files (MDL molfile).  
3.8. MultiCASE
This software, developed by MultiCASE Inc. (http://multicase.com/), implements the so-
called CASE (Computer Automated Structure Evaluation) approach, and is referred to in 
different ways (MCASE or MC4PC), depending on the software version and computer 
platform and its successor. The program automatically generates predictive models from 
datasets provided by the user. It is based on a fragment-based technology sometimes referred 
to as the CASE approach (Klopman & Rosenkranz 1994). The program performs a 
hierarchical statistical analysis of a database to discover substructures that appear mostly in 
active molecules thus being with high probability responsible for the observed activity. 
Initially, it identifies the statistically most significant substructure within the training set. This 
fragment, labelled the top biophore, is considered responsible for the activity of the largest 
possible number of active molecules. The active molecules containing this biophore are then 
removed from the database, and the remaining ones are submitted to a new analysis for 
identification of the next biophore. The procedure is repeated until either the activity of all the 
molecules in the training set has been accounted for or no additional statistically significant 
substructure can be found. Then for each set of molecules containing a specific biophore, the 
program identifies additional parameters called modulators, which can be used to derive 
QSAR within the reduced set of congeneric molecules. The modulators consist of certain 
substructures or physicochemical parameters that significantly enhance or diminish the 
activity attributable to the biophore. QSARs are then derived by incorporating the biophores 
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properties and a range of toxicological endpoints, including carcinogenicity, mutagenicity, 
teratogenicity, irritation, developmental toxicity, and acute toxicity. For the endpoints, the 
software uses it own toxicity scale, from 0 to 100 CASE units, to cover the range from 
inactive, marginally active and active. In many cases, it is difficult to relate these CASE units 
to traditional measures of toxicity.
3.9. OASIS TIMES 
The Tissue MEtabolism Simulator (TIMES), developed by LMC (Bourgas University, 
Bulgaria; http://oasis-lmc.org/) integrates on the same platform a metabolic simulator and 
QSAR models for predicting toxicity of selected metabolites. The metabolic simulator 
generates plausible metabolic maps from a comprehensive library of biotransformations and 
abiotic reactions. It allows prioritization of chemicals according to toxicity of their 
metabolites. OASIS TIMES can be used to predict a range of endpoints, including acute 
toxicity for different species, receptor-binding affinities (oestrogen, androgen and aryl 
hydrocarbon receptors), mutagenicity and chromosomal aberration, while also accounting for 
the metabolic activation of chemicals.
3.10. TOPKAT
This QSAR-based system, developed by Accelrys Inc. (http://accelrys.com/), makes 
predictions of a range of toxicological endpoints, including mutagenicity, developmental 
toxicity, rodent carcinogenicity, rat chronic LOAEL, rat Maximum Tolerated Dose (MTD) 
and rat oral LD50. The QSARs are developed by regression analysis for continuous endpoints 
and by discriminant analysis for categorical endpoints. TOPKAT models are derived by using 
a range of two-dimensional molecular, electronic and spatial descriptors. TOPKAT estimates 
the confidence in the prediction by applying the patented Optimal Predictive Space (OPS) 
validation method. The OPS is TOPKAT’s formulation of the model applicability domain - a 
unique multivariate descriptor space in which a given model is considered to applicable. Any 
prediction generated for a query structure outside of the OPS space is considered unreliable. 
3.11. ToxAlert
This tool, also a module of the Pallas suite, flags compounds for hazards associated with 
specific pharmacophores (structural alerts). The prediction is based on an improved version of 
the knowledge base implemented in HazardExpert, and in addition to the overall toxicity 
profile, it provides probability percentages for different toxicity endpoints. Like 
HazardExpert, it has an open knowledge base, allowing additions and modifications to the 
underlying data.
3.12. q-Tox
A tool developed by Quantum Pharmaceuticals (http://q-pharm.com/) utilises a novel 
approach for the prediction of toxicity. It is based on the premise that biological activity 
results from the capacity of small molecules to modulate the activity of the proteome. 
Publically available IC50 values for several proteins were used to build interpretation models. 
The tool predicts several toxicity endpoints, mouse, rat, dog rabbit LD50 and also side effects.
The draw back of the tool is that the estimated calculation time is 5 to 10 hours per molecule.
73.13. CSGenoTox
Is a tool which predicts Ames mutagenicity, developed by ChemSilico
(http://chemsilico.com/). Topological molecular descriptors were selected with neural 
network analysis to optimize the relationship between experimental and calculated mutagenic 
index. Mutagenicity is expressed as 1 for a mutagen and 0 for a non-mutagen.
4. Conclusions
The aim of this review is to summarise the availability of software models for toxicity 
prediction. The models are based on a wide variety of approaches, including models that are 
mechanistically-based or at least mechanistically plausible, and models that have no apparent 
mechanistic basis.
The availability and quality of the models varies depending on the endpoint: in general, 
models for acute toxicity are more reliable than “complex” endpoints which comprise a large 
number of partially understood mechanisms, such as chronic toxicity, systemic toxicities, and 
reproductive toxicity. For mutagenicity and carcinogenicity, there is a relative abundance of 
reliable models, mainly based on the fact that these toxic effects are driven by chemical 
reactivity (electrophilic binding to DNA and/or proteins).
The applicability of individual software models to specific groups of chemicals is outside the 
scope of this review. Often, the validation characteristics of software models are insufficiently 
documented to provide sufficient confidence that the models can be used reliably for the 
chemical(s) of interest. In many cases, details of the predictive algorithm are not transparent. 
One the one hand, it can be argued that this is not essential since the algorithm is implemented 
directly by the software; on the other hand, it can be argued that the absence of the algorithm 
undermines confidence in the predictions, since the basis of prediction is not transparent.  
Furthermore, the applicability domains of the models are not always transparent, although 
some software tools provide assessments of prediction reliability that are based on 
applicability domain considerations.
It is concluded that further research is needed to assess the applicability of currently available 
software models to chemical groups / inventories of interest, and these assessments should be 
documented according to internationally agreed principles and reporting formats, such as the 
QSAR Model Reporting Format (QMRF) and the QSAR Prediction Reporting Format 
(QPRF). An increasingly range of QMRFs for both software models and literature-based 
models are freely accessible from the JRC QSAR Model database 
(http://ecb.jrc.ec.europa.eu/qsar/qsar-tools/index.php?c=QRF). For further information on the 
documentation of models and their predictions, the reader is referred to other publications 
(ECHA, 2008; Worth, 2010) as well as guidance notes published by the European Chemicals 
Agency (ECHA 2010a,b).
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96. Tables
Table 1. Commonly used freely available software tools
Software and developer Availability Methodology Comment
EPI Suite; US EPA
http://www.epa.gov/oppt/exposure/pubs/episuite.htm
Freely available Statistical Downloadable tool suitable for non-
specialised users.
OncoLogic®; US EPA
http://www.epa.gov/oppt/newchems/tools/oncologic.htm
Freely available Knowledge-based Downloadable tool suitable for users with 
a limited knowledge of chemistry. 
Transparent predictions.
Toxtree; EC - JRC
http://ecb.jrc.ec.europa.eu/qsar/qsar-tools
Freely available Hybrid - Statistical and 
knowledge-based
Downloadable and open source tool 
suitable for non-specialised users.
Toxmatch; EC - JRC
http://ecb.jrc.ec.europa.eu/qsar/qsar-tools
Freely available Statistical Downloadable and open source research
tool for chemical similarity analysis. 
Supports chemical grouping and read-
across. Specialised expertise required.
OECD QSAR Toolbox
http://www.oecd.org
Freely available Hybrid - Statistical and 
knowledge-based
Downloadable research tool for profiling 
mechanisms, chemical grouping and read-
across. Specialised expertise required.
Lazar; In Silico Toxicology (Freiburg university)
http://lazar.in-silico.de
Freely available Statistical Web-accessible and open source tool 
under development in EU OpenTox 
project. Suitable for non-specialised 
users.
Caesar project models
http://www.caesar-project.eu/software/index.htm
Freely available Statistical Web-accessible and open source tool 
developed in EU Caesar project. Suitable 
for non-specialised users.
PASS 
http://195.178.207.233/PASS/index.html
Freely available Statistical Web-accessible, generates predictions on 
line upon registration.
T.E.S.T.
http://www.epa.gov/nrmrl/std/cppb/qsar/#TEST
Freely available Statistical Downloadable and open source tool for 
toxicity estimation developed by US 
EPA. Suitable for non-specialised users.
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Table 2. Commonly used commercial software tools
Software and developer Availability Methodology Comment
ADMET Predictor; Simulations Plus
http://www.simulations-plus.com
Commercial Statistical
TOPKAT; Accelrys Inc
http://www.accelrys.com
Commercial Statistical Algorithms are not transparent.
Pallas software (HazardExpert, ToxAlert; MetabolExpert); CompuDrug Ltd
http://www.compudrug.com
Commercial Knowledge-based
Derek; Lhasa Ltd
http://www.lhasalimited.org
Commercial Knowledge-based Knowledge base is transparent.
MultiCASE; MultiCASE Inc
http://www.multicase.com
Commercial Statistical
MDL QSAR
http://www.symyx.com/
Commercial Statistical Research tool.
BioEpisteme
http://www.prousresearch.com/
Commercial Statistical Research tool.
ACD ToxSuite (ToxBoxes); ACDLabs and Pharma Algorithms
Product description: http://www.acdlabs.com/products/admet/tox/
Free web application: http://www.pharma-algorithms.com/webboxes/
Commercial (free 
web application)
Statistical (neural 
networks)
Easy to use. Algorithms are not 
transparent.
OASIS TIMES; LMC, Bourgas University, Bulgaria
http://www.oasis-lmc.org
Commercial Hybrid - Statistical and 
knowledge-based
Molcode Toolbox; Molcode Ltd, Estonia
http://molcode.com/
Commercial Statistical Easy to use. Algorithms and underlying 
data are transparent.
q-Tox Commercial Statistical
CSGenoTox Commercial Statistical
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ACD/Tox Suite (ToxBoxes) Commercial • • •
ADMET Predictor (Simulations Plus Inc.) Commercial • (1) • • • •
BioEpisteme Commercial • • •
Caesar project models (Mario Negri Institute) Freely available • • •
Derek (Lhasa Ltd) Commercial • • • • • • • •
HazardExpert (CompuDrug) Commercial • • • •
Lazar (In Silico Toxicology; Freiburg university) Freely available • (1) • • •
Leadscope (Leadscope) Commercial • • • • • •
MCASE/MC4PC (MultiCASE) Commercial • • • • • • • •
MDL QSAR (MDL) Commercial • • (1) • • • •
OASIS-TIMES (Laboratory of Mathematical Chemistry, Bourgas 
University)
Commercial • •
OncoLogic (US EPA) Freely available •
Pallas Suite including ToxAlert, Cytotoxicity (CompuDrug) Commercial • • • •
TerraQSAR (TerraBase) Commercial • •
TOPKAT (Accelrys) Commercial • • • • •
Toxtree (JRC) Freely available • (2) • •
Molcode Toolbox ( Molcode Ltd) Commercial • • • • •
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)
PASS (Institute of Biomedical Chemistry of the Russian Academy of  
Medical Sciences, Moscow)
Freely available • • • • • • •
q-Tox (Quantum Pharmaceuticals) Commercial •
T.E.S.T. (US EPA) Freely available • •
CSGenoTox (ChemSilico) Commercial •(4)
(1) maximum tolderated dose in humans; (2) Cramer classification tree; (3) immunotoxicity other than skin sensitisaton; (4) prediction of the mutagenic index for Ames test mutagenicity
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Table 4. Software capable of predicting toxicological endpoints 
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ACD/Tox Suite (ToxBoxes) Commercial • •
ADMET Predictor (Simulations Plus Inc.) Commercial
BioEpisteme Commercial
Caesar project models (Mario Negri Institute) Freely available •
Derek (Lhasa Ltd) Commercial • • • • •
HazardExpert (CompuDrug) Commercial • •
Lazar (In Silico Toxicology; Freiburg university) Freely available
Leadscope (Leadscope) Commercial
MCASE/MC4PC (MultiCASE) Commercial • •
MDL QSAR (MDL) Commercial • •
OASIS-TIMES (Laboratory of Mathematical Chemistry, Bourgas 
University)
Commercial •
OncoLogic (US EPA) Freely available
Pallas Suite including ToxAlert, Cytotoxicity (CompuDrug) Commercial
TerraQSAR (TerraBase) Commercial •
TOPKAT (Accelrys) Commercial • • • •
Toxtree (JRC) Freely available • • • •
Molcode Toolbox ( Molcode Ltd) Commercial • •
PASS Freely available •
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